Singapore · Delayed Price · Currency is SGD Pacific Radiance Statistics
Total Valuation
SGX:RXS has a market cap or net worth of SGD 130.32 million. The enterprise value is 119.78 million.
| Market Cap | 130.32M |
| Enterprise Value | 119.78M |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | May 6, 2025 |
Share Statistics
SGX:RXS has 1.45 billion shares outstanding. The number of shares has increased by 38.71% in one year.
| Current Share Class | 1.45B |
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | +38.71% |
| Shares Change (QoQ) | +9.17% |
| Owned by Insiders (%) | 73.39% |
| Owned by Institutions (%) | 1.71% |
| Float | 378.04M |
Valuation Ratios
The trailing PE ratio is 5.52 and the forward PE ratio is 1.66.
| PE Ratio | 5.52 |
| Forward PE | 1.66 |
| PS Ratio | 2.08 |
| PB Ratio | 1.13 |
| P/TBV Ratio | 1.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 40.74 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.35, with an EV/FCF ratio of -14.23.
| EV / Earnings | 5.15 |
| EV / Sales | 1.91 |
| EV / EBITDA | 6.35 |
| EV / EBIT | 9.79 |
| EV / FCF | -14.23 |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.61 |
| Quick Ratio | 2.59 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.53 |
| Debt / FCF | -1.10 |
| Interest Coverage | 18.58 |
Financial Efficiency
Return on equity (ROE) is 22.70% and return on invested capital (ROIC) is 6.03%.
| Return on Equity (ROE) | 22.70% |
| Return on Assets (ROA) | 4.71% |
| Return on Invested Capital (ROIC) | 6.03% |
| Return on Capital Employed (ROCE) | 8.64% |
| Revenue Per Employee | 368,200 |
| Profits Per Employee | 136,833 |
| Employee Count | 170 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 121.80 |
Taxes
| Income Tax | -3.95M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.00% in the last 52 weeks. The beta is 0.36, so SGX:RXS's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +125.00% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 67.74 |
| Average Volume (20 Days) | 17,589,635 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SGX:RXS had revenue of SGD 62.59 million and earned 23.26 million in profits. Earnings per share was 0.02.
| Revenue | 62.59M |
| Gross Profit | 25.37M |
| Operating Income | 10.81M |
| Pretax Income | 19.31M |
| Net Income | 23.26M |
| EBITDA | 16.81M |
| EBIT | 10.81M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 19.63 million in cash and 9.29 million in debt, giving a net cash position of 10.33 million or 0.01 per share.
| Cash & Cash Equivalents | 19.63M |
| Total Debt | 9.29M |
| Net Cash | 10.33M |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 115.15M |
| Book Value Per Share | 0.08 |
| Working Capital | 32.78M |
Cash Flow
In the last 12 months, operating cash flow was 3.20 million and capital expenditures -11.62 million, giving a free cash flow of -8.42 million.
| Operating Cash Flow | 3.20M |
| Capital Expenditures | -11.62M |
| Free Cash Flow | -8.42M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 40.53%, with operating and profit margins of 17.28% and 37.16%.
| Gross Margin | 40.53% |
| Operating Margin | 17.28% |
| Pretax Margin | 30.86% |
| Profit Margin | 37.16% |
| EBITDA Margin | 26.86% |
| EBIT Margin | 17.28% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 0.56%.
| Dividend Per Share | 0.00 |
| Dividend Yield | 0.56% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -38.71% |
| Shareholder Yield | -38.16% |
| Earnings Yield | 17.85% |
| FCF Yield | -6.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 12, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Sep 12, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
SGX:RXS has an Altman Z-Score of 0.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 6 |